TIMP3 (tissue inhibitors of metalloproteinase 3) was shown to be associated with metastasis and poor survival in serous ovarian cancer by regulating TGF-beta signaling [35]. This evidence concerns the gene TIMP3 and ovarian serous adenocarcinoma.